Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

16. September 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3077


	Artikel 1 - 20 / 61535

	Targeting drug efflux in pancreatic cancer: what the PANTAX trial teaches us about resisting resistance. Ann Pancreat Cancer Abdel-Razeq N, Mukhopadhyay D, Babiker H. PMID: 42746509 [PubMed]
	Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap. Front Oncol Gu Y, Luo X, Zhang Y, Tang J, Wang Z. PMID: 42746379 [PubMed]
	Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world study. Cancer Persano M, Casadei-Gardini A, Fornaro L, Satake T, Abidoye O, Lo Prinzi F, Antonuzzo L, Kim JW, Bergamo F, Bathon M, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Niger M, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Lamarca A, Giordano G, Finkelmeier F, Oneda E, Avallone A, Perkhofer L, Kim IH, Garajova I, Corallo S, Fenocchio E, Dell'Aquila E, Pirrone C, Lucidi L, Tesini G, Valenzi E, Diana A, Yoo C, Schirripa M, Formica V, Rodriquenz MG, Scartozzi M, Adeva J, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan SL, Ikeda M, Bekaii-Saab T, Lucchetti J, Lavacchi D, Kang M, Balsano R, Salani F, Camera S, Masi G, Lonardi S, Vogel A, Rimassa L, Rimini M. PMID: 42745498 [PubMed - indexed for MEDLINE]
	Long-Term Association Between GLP-1 Receptor Agonist Use and Incident Pancreatic Cancer: A Propensity Score-Matched Retrospective Cohort Study Using the TriNetX Network. J Gastrointest Cancer Kazi MAI, Khan J, Mufarrih SM, Siddiqui M, Ansari HUH, Ahmed M, Qureshi I, Al-Sabban A, Karnik NP, Gilman A, Singh S, Canakis A. PMID: 42745130 [PubMed - indexed for MEDLINE]
	Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS(G12D) mutations: a phase 1 trial. Nat Med Ai X, Song Z, Wu L, Zhou A, Cheng D, Zong H, Wu H, Niu Z, Sun Y, Zhu L, Li Z, Deng Y, Yuan Y, Qu X, Zhao H, Du Y, Li Z, Wang Y, Shen H, Zhu H, Zheng C, Wang S, Cui Z, Tai L, Lu S. PMID: 42745055 [PubMed - indexed for MEDLINE]
	Survival After Irreversible Electroporation in Unresectable Locally Advanced Pancreatic Cancer: A Meta-analysis. J Surg Res Hajibandeh S, Hussain M, Abu Taha K, Sujathan V, Finch LM, Hajibandeh S, Nadarajah V, Kadamapuzha J, Jegatheeswaran S, Jamdar S, Stathakis P, Deshpande R, Siriwardena AK, Satyadas T, de Liguori Carino N. PMID: 42743900 [PubMed - as supplied by publisher]
	Machine learning-supported identification of necrosis in colorectal and pancreatic cancer spheroids. PLoS One Lozano MM, Wanzenboeck HD, Prado-López S. PMID: 42743162 [PubMed - indexed for MEDLINE]
	Early postoperative serum IL-6 may contribute to risk stratification for pancreas-specific complications after pancreatic resection. Langenbecks Arch Surg Schulte-Hürmann H, Koca F, Wicke J, Mazzella E, Benkö T, Wiegering A, Petrova E. PMID: 42742801 [PubMed - indexed for MEDLINE]
	Associations of oral microbiome diversity with prevalent cancer: a population-based cross-sectional study. Arch Microbiol An Y, Pang C, Wu Z, Chu Y, Wan W, Gao S, Pu N. PMID: 42742726 [PubMed - indexed for MEDLINE]
	Surgical outcomes after robot-assisted versus laparoscopic pancreatoduodenectomy: multicentre propensity-matched comparison from the Italian Group of Minimally Invasive Pancreatic Surgery. BJS Open Quero G, Menghi R, Napoli N, Ripolli A, Ferrari G, Mazzola M, Bannone E, Butturini G, Viola MG, Garatti M, Tebala G, Di Benedetto F, Moraldi L, Molino C, Alfieri S, Bracale U, Troisi R, Dalla Valle R, Vivarelli M, Jovine E, Memeo R, Garulli G, Ottaviani L, Berti S, Coratti A, Ercolani G, Salvia R, Morelli L, Casadei R, Coppola R, Brolese A, Tondolo V, Zerbi A, Boggi U, IGOMIPS Registry Study Group. PMID: 42742083 [PubMed - indexed for MEDLINE]
	Efficacy of UFT combined with radiotherapy in advanced pancreatic cancer: a systematic review and meta-analysis. Front Oncol Shang X, Wang X, Cen J, Yang F, Li J, Zhao H. PMID: 42741119 [PubMed]
	The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Clin Public Health Guidel Leeuwenburgh LC, Holze M, Akhoundzadeh D, Alsourani A, Jimenez RA, Andel PCM, van Houweninge CB, Balduzzi A, Bruna CL, Casciani F, Cattelani A, van Diepen AE, Driessens H, Droogh DHM, Fritzsche JA, van Gansewinkel E, Genova L, Gehrels AM, Dueñas GG, Guastella R, Hoeijmakers LSM, Hoogteijling TJ, Javed AA, Aktas BK, Kinny-Köster B, Lamoré A, Seng Liem K, Lionetto G, Faro LL, Lutter L, Mastronardi M, Maurer CH, Montorsi R, Musa J, Rompen IF, Scheepens JCM, Sochorová D, Stoop TF, Tezcan N, Uijterwijk BA, Vella R, Vernuccio F, Voermans RP, Hilal MA, Adsay V, Algül H, Ambrosini V, Archibugi L, Backman E, Barbu ST, Boggi U, Borge-Andersen C, Burgdorf SK, Clarkson A, van Cutsem E, Cuyle PJ, Daamen LA, Rosa P, den Dulk M, de Los Rios CD, Drury A, Esposito I, Everett SM, Sarasqueta AF, Frigerio I, Koerkamp BG, Hackert T, Huguet F, Kartalis N, Letsch A, Langenberg P, Levett D, Liposits G, Malats N, van Malenstein H, Malleo G, Maravic Z, Marchegiani G, Martins A, Meijerink MR, Michalski CW, Mieog JSD, Moka E, Mukherjee S, Nanni C, Orsi F, Papamichael D, Partelli S, Payne C, Pergolini I, Radenkovic D, Roberts KJ, Salvia R, Sauvanet A, Scorsetti M, Seebo M, Seufferlein T, Stättner S, Vanbiervliet G, Verbeke CS, Volk T, Werner J, Wilmink JW, Zins M, Conroy T, Pfeiffer P, Ducreux M, Ali M, Langendam M, Vali Y, Rangelova EB, Besselink MG, Multi. PMID: 42740762 [PubMed]
	Biglycan Secreted by Tumor Stromal Cells Is a Predictive Marker for the Early Recurrence of Pancreatic Cancer. Pathol Int Tanaka H, Maishi N, Matsuda A, Morimoto H, Fujii M, Tsumita T, Mitsuhashi T, Matsuno Y, Hida Y, Nakamura T, Hirano S, Hida K. PMID: 42740565 [PubMed - indexed for MEDLINE]
	Recorded Early Imaging Responses After Transarterial Chemoembolization Plus Lenvatinib Versus Transarterial Chemoembolization Without Documented Lenvatinib for Unresectable Hepatocellular Carcinoma: A Vietnamese Cohort Study. J Clin Med Minh VL, Hung NV, Anh PT, Anh PT, Thong PM. PMID: 42739846 [PubMed]
	Mitoxyperilysis Drives Immunosuppressive Tumor Microenvironment Remodeling and Hepatocellular Carcinoma Progression via ANXA1-Mediated Macrophage M2 Polarization. Cancers (Basel) Qin M, He W, Wu G. PMID: 42738308 [PubMed]
	Beyond Canonical Neoantigens: Emerging Technologies for Identification of Noncanonical Antigens and Implications for Personalized Cancer Vaccines. Cancers (Basel) Yang Y, Kane T, Abdelzaher AT, Goedegebuure SP, Gillanders WE. PMID: 42738301 [PubMed]
	Targeting Reactive Species Stress and Nutrient Sensing to Enhance NK-Cell Function: Mechanistic Strategies for Overcoming Pancreatic Cancer Progression and Resistance Through Supplement Therapy. Int J Mol Sci Fanijavadi S, Jensen LH. PMID: 42737789 [PubMed - indexed for MEDLINE]
	Metabolic Dysfunction and Related Dietary Exposures in Relation to Pancreatic Cancer Risk: A Review of the Evidence. Int J Mol Sci Yang J, Huang Y, Lophatananon A, Muir KR. PMID: 42737603 [PubMed - indexed for MEDLINE]
	Protease-Activated Receptor-2 as a Proteolytic Rheostat in Colorectal and Pancreatic Cancer: From Mechanism to Biomarker-Guided Therapy. Int J Mol Sci Yeganeh HT, Sellat M, Anis Z, Chiri R, Patnaik R, Gambhir S, Banerjee Y. PMID: 42737430 [PubMed - indexed for MEDLINE]
	The use of blood test trends in cancer detection: a scoping review. Diagn Progn Res Zhu S, Friedemann Smith C, Collins KK, Ziyenge SE, Murphy J, de Vere Hunt I, Brubert Z, Roberts N, Morris EJA, Hobbs R, Nicholson BD, Virdee PS. PMID: 42736584 [PubMed]

Artikel 1 - 20 / 61535

Seite 1 von 3077



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung